Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interstitial Lung Disease in Early Rheumatoid Arthritis

NCT03977415 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT03977415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03977415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interstitial Lung Disease in Early Rheumatoid Arthritis
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Unknown status
Start date
March 27, 2018
Completion date
August 1, 2021
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, rheumatoid arthritis